Logo image of IMKTA

INGLES MARKETS INC-CLASS A (IMKTA) Stock Fundamental Analysis

NASDAQ:IMKTA - Nasdaq - US4570301048 - Common Stock - Currency: USD

62.16  +1.01 (+1.65%)

After market: 62.16 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to IMKTA. IMKTA was compared to 41 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and the financial health of IMKTA get a neutral evaluation. Nothing too spectacular is happening here. IMKTA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year IMKTA was profitable.
In the past year IMKTA had a positive cash flow from operations.
Each year in the past 5 years IMKTA has been profitable.
Each year in the past 5 years IMKTA had a positive operating cash flow.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

IMKTA has a Return On Assets (2.47%) which is comparable to the rest of the industry.
IMKTA has a Return On Equity (3.94%) which is comparable to the rest of the industry.
IMKTA has a Return On Invested Capital of 4.06%. This is in the lower half of the industry: IMKTA underperforms 60.98% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IMKTA is above the industry average of 7.97%.
The last Return On Invested Capital (4.06%) for IMKTA is well below the 3 year average (10.21%), which needs to be investigated, but indicates that IMKTA had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.47%
ROE 3.94%
ROIC 4.06%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

The Profit Margin of IMKTA (1.14%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of IMKTA has remained more or less at the same level.
The Operating Margin of IMKTA (2.20%) is comparable to the rest of the industry.
IMKTA's Operating Margin has declined in the last couple of years.
IMKTA has a Gross Margin (23.50%) which is in line with its industry peers.
IMKTA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.2%
PM (TTM) 1.14%
GM 23.5%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IMKTA is creating some value.
The number of shares outstanding for IMKTA remains at a similar level compared to 1 year ago.
IMKTA has less shares outstanding than it did 5 years ago.
IMKTA has a better debt/assets ratio than last year.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

IMKTA has an Altman-Z score of 4.23. This indicates that IMKTA is financially healthy and has little risk of bankruptcy at the moment.
IMKTA's Altman-Z score of 4.23 is in line compared to the rest of the industry. IMKTA outperforms 58.54% of its industry peers.
IMKTA has a debt to FCF ratio of 24.41. This is a negative value and a sign of low solvency as IMKTA would need 24.41 years to pay back of all of its debts.
IMKTA has a Debt to FCF ratio of 24.41. This is in the lower half of the industry: IMKTA underperforms 68.29% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that IMKTA is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.32, IMKTA is doing good in the industry, outperforming 60.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 24.41
Altman-Z 4.23
ROIC/WACC0.57
WACC7.14%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

IMKTA has a Current Ratio of 3.19. This indicates that IMKTA is financially healthy and has no problem in meeting its short term obligations.
IMKTA's Current ratio of 3.19 is amongst the best of the industry. IMKTA outperforms 92.68% of its industry peers.
A Quick Ratio of 1.46 indicates that IMKTA should not have too much problems paying its short term obligations.
IMKTA's Quick ratio of 1.46 is amongst the best of the industry. IMKTA outperforms 87.80% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 1.46
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

IMKTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.88%.
The Earnings Per Share has been growing slightly by 6.65% on average over the past years.
The Revenue has decreased by -7.79% in the past year.
IMKTA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.06% yearly.
EPS 1Y (TTM)-64.88%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-52.38%
Revenue 1Y (TTM)-7.79%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-2.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2022 5 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.07, which indicates a rather expensive current valuation of IMKTA.
Based on the Price/Earnings ratio, IMKTA is valued a bit cheaper than 60.98% of the companies in the same industry.
IMKTA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.35.
Industry RankSector Rank
PE 19.07
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

IMKTA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IMKTA is cheaper than 82.93% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IMKTA is valued a bit more expensive than 65.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 54.96
EV/EBITDA 5.68
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.87
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.09%, IMKTA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.17, IMKTA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, IMKTA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.09%

5.2 History

The dividend of IMKTA has a limited annual growth rate of 0.12%.
IMKTA has been paying a dividend for at least 10 years, so it has a reliable track record.
IMKTA has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

IMKTA pays out 19.81% of its income as dividend. This is a sustainable payout ratio.
The dividend of IMKTA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP19.81%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

More info and screens

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (6/20/2025, 8:00:02 PM)

After market: 62.16 0 (0%)

62.16

+1.01 (+1.65%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners92.45%
Inst Owner Change2.03%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.18B
Analysts84.44
Price TargetN/A
Short Float %4.79%
Short Ratio5.32
Dividend
Industry RankSector Rank
Dividend Yield 1.09%
Yearly Dividend0.65
Dividend Growth(5Y)0.12%
DP19.81%
Div Incr Years0
Div Non Decr Years11
Ex-Date04-10 2025-04-10 (0.165)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.07
Fwd PE N/A
P/S 0.22
P/FCF 54.96
P/OCF 6.02
P/B 0.75
P/tB 0.75
EV/EBITDA 5.68
EPS(TTM)3.26
EY5.24%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.13
FCFY1.82%
OCF(TTM)10.32
OCFY16.6%
SpS284.91
BVpS82.77
TBVpS82.77
PEG (NY)N/A
PEG (5Y)2.87
Profitability
Industry RankSector Rank
ROA 2.47%
ROE 3.94%
ROCE 5.36%
ROIC 4.06%
ROICexc 4.69%
ROICexgc 4.69%
OM 2.2%
PM (TTM) 1.14%
GM 23.5%
FCFM 0.4%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
ROICexc(3y)11.97%
ROICexc(5y)12.99%
ROICexgc(3y)11.97%
ROICexgc(5y)12.99%
ROCE(3y)13.5%
ROCE(5y)15.58%
ROICexcg growth 3Y-23.42%
ROICexcg growth 5Y-0.13%
ROICexc growth 3Y-23.42%
ROICexc growth 5Y-0.13%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
F-Score5
Asset Turnover2.16
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 24.41
Debt/EBITDA 2.07
Cap/Depr 139.43%
Cap/Sales 3.22%
Interest Coverage 250
Cash Conversion 80.23%
Profit Quality 34.67%
Current Ratio 3.19
Quick Ratio 1.46
Altman-Z 4.23
F-Score5
WACC7.14%
ROIC/WACC0.57
Cap/Depr(3y)141.53%
Cap/Depr(5y)130.04%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.85%
Profit Quality(3y)57.87%
Profit Quality(5y)73.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-64.88%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-52.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.79%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-2.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.02%
EBIT growth 3Y-20.18%
EBIT growth 5Y3.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.85%
FCF growth 3Y-32.19%
FCF growth 5Y0.76%
OCF growth 1Y-29.62%
OCF growth 3Y-5.01%
OCF growth 5Y4.42%